Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Platz

Showing results (521-530 of 590) with videos related to

Pageof 59
Sort By:
Plos Medicine|September 24, 2024
Development, characterization, and replication of proteomic aging clocks: Analysis of 2 population-based cohortsShuo Wang, Zexi Rao, Rui Cao, et al.
International Journal of Cancer|October 10, 2020
Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization studyNiki L Dimou, Nikos Papadimitriou, Daniela Mariosa, et al.
The Prostate|January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trialDanyelle A Winchester, Bora Gurel, Cathee Till, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 26, 2020
Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention TrialLauren M Hurwitz, Ibrahim Kulac, Berrak Gumuskaya, et al.
Carcinogenesis|November 15, 2007
Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studiesKim N Danforth, Richard B Hayes, Carmen Rodriguez, et al.
The Prostate|June 6, 2015
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Cancer Causes & Control : CCC|June 14, 2011
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control studySong Yao, Cathee Till, Alan R Kristal, et al.
Urology|March 4, 2015
Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade diseaseAshraful Hoque, Song Yao, Cathee Till, et al.
Nature Communications|October 29, 2025
Multi-cohort high-dimensional proteomics reveals early risk markers for lymphoid cancer subtypesP Martijn Kolijn, Karl Smith-Byrne, Vernon Burk, et al.
Research Square|September 2, 2025
Multi-Cohort High-Dimensional Proteomics Reveals Early Risk Markers for Lymphoid Cancer SubtypesP Martijn Kolijn, Karl Smith-Byrne, Vernon Burk, et al.
Pageof 59

Showing results (521-530 of 590) with videos related to

Sort By:
Pageof 59
Plos Medicine|September 24, 2024
Development, characterization, and replication of proteomic aging clocks: Analysis of 2 population-based cohortsShuo Wang, Zexi Rao, Rui Cao, et al.
International Journal of Cancer|October 10, 2020
Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization studyNiki L Dimou, Nikos Papadimitriou, Daniela Mariosa, et al.
The Prostate|January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trialDanyelle A Winchester, Bora Gurel, Cathee Till, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 26, 2020
Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention TrialLauren M Hurwitz, Ibrahim Kulac, Berrak Gumuskaya, et al.
Carcinogenesis|November 15, 2007
Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studiesKim N Danforth, Richard B Hayes, Carmen Rodriguez, et al.
The Prostate|June 6, 2015
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Cancer Causes & Control : CCC|June 14, 2011
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control studySong Yao, Cathee Till, Alan R Kristal, et al.
Urology|March 4, 2015
Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade diseaseAshraful Hoque, Song Yao, Cathee Till, et al.
Nature Communications|October 29, 2025
Multi-cohort high-dimensional proteomics reveals early risk markers for lymphoid cancer subtypesP Martijn Kolijn, Karl Smith-Byrne, Vernon Burk, et al.
Research Square|September 2, 2025
Multi-Cohort High-Dimensional Proteomics Reveals Early Risk Markers for Lymphoid Cancer SubtypesP Martijn Kolijn, Karl Smith-Byrne, Vernon Burk, et al.
Pageof 59